Current Signal Transduction Therapy

ISSN (Print): 1574-3624
ISSN (Online): 2212-389X

Volume 17 , Issues 3, 2022

This journal supports open access

Back Journal Home
Topic(s) Covered

3 Topic(s)

View

Aims & Scope

In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.

The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.

Abstracted/Indexed in


BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE, Genamics JournalSeek, Google Scholar Index Copernicus, J-Gate, JournalTOCs, MediaFinder®-Standard Periodical Directory, Open Abstracts (I4OA), PubsHub, QOAM, Scilit, Scopus, Suweco CZ, TOC Premier and Ulrich's Periodicals Directory

Special Offers

Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.

30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.

COPE COMPLIANT
© 2022 Bentham Science Publishers | Privacy Policy